We are live on ! Find out more
INBS icon

Intelligent Bio Solutions

10 hedge funds and large institutions have $3.36M invested in Intelligent Bio Solutions in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,055% more capital invested

Capital invested by funds: $291K → $3.36M (+$3.07M)

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

100% more funds holding

Funds holding: 510 (+5)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
10
Holders Change
+5
Holders Change %
+100%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AFM
1
Anson Funds Management
Texas
$2.25M +$2.28M +238 New
BCM
2
Bridgeway Capital Management
Texas
$465K +$392K +41 +513%
WP
3
WealthShield Partners
North Carolina
$194K +$191K +20 New
VF
4
Virtu Financial
New York
$98K +$95.7K +10 New
Goldman Sachs
5
Goldman Sachs
New York
$77K +$76.5K +8 New
Jane Street
6
Jane Street
New York
$75K +$76.5K +8 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$74K +$76.5K +8 New
Citadel Advisors
8
Citadel Advisors
Florida
$68K -$47.8K -5 -42%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$43K +$47.8K +5 New
TRCT
10
Tower Research Capital (TRC)
New York
$14K
BlackRock
11
BlackRock
New York
$2K -$9.57K -1 Closed
UBS Group
12
UBS Group
Switzerland
-$9K -1 Closed
VFA
13
Valeo Financial Advisors
Indiana
-$6K

INBS Hedge Fund Activity: Q2 2021 in Review

10 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q2 2021, worth a combined $3.36M — up 1,055% from $291K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new INBS positions and 2 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $2.28M. The largest seller was Citadel Advisors, cutting an estimated $47.8K.

  • 10 institutional investors held Intelligent Bio Solutions (INBS) as of Q2 2021, up from 5 in Q1 2021.
  • Funds reported $3.36M of Intelligent Bio Solutions stock for Q2 2021, up 1,055% quarter-over-quarter.
  • 7 funds opened new Intelligent Bio Solutions positions in Q2 2021 and 2 closed out, a net change of +5 holders.
  • The largest Intelligent Bio Solutions buyer in Q2 2021 was Anson Funds Management, an estimated $2.28M added.
  • The largest Intelligent Bio Solutions seller in Q2 2021 was Citadel Advisors, an estimated $47.8K sold.

Based on aggregated 13F filings for Q2 2021.